1.
US Tariffs on Indian Goods to Push Up Healthcare Costs, Warn Industry Experts
The US healthcare sector may face rising costs as a result of a 25% tariff and additional penalties on Indian imports, including pharmaceuticals and medical devices. Experts warn of declining profits, stalled R&D, and shifting global trade dynamics.
